PSR SUPPLIER REPORT
Independent review of supplier documentation, analytical testing evidence, lot traceability, pricing visibility, and company transparency.
REPORT STATUS
Initial Review
LAST REVIEWED
September 2026
SUPPLIER TYPE
Research-use supplier
LOCATION LISTED
Bucharest, Romania
AFFILIATE DISCLOSURE
PSR may receive compensation when visitors access Healius Peptides through certain referral links. Affiliate relationships do not determine PSR scores, methodology, findings, rankings, or editorial conclusions.
PRELIMINARY PSR ASSESSMENT
88 / 100 · STRONG TRANSPARENCY
WEIGHTED OVERALL PSR TRANSPARENCY SCORE
88 / 100
Preliminary assessment pending continued documentation review. Scores reflect transparency evidence and are not a certification, guarantee, safety determination, or human-use recommendation.
DOCUMENTATION QUALITY · 25%
91 / 100
TESTING EVIDENCE · 25%
82 / 100
LOT TRACEABILITY · 20%
94 / 100
PRICING TRANSPARENCY · 15%
94 / 100
SUPPLIER TRANSPARENCY · 15%
82 / 100
EXECUTIVE SUMMARY
A neutral reading of the public record.
Healius Peptides maintains a substantial public documentation framework built around a searchable lot-level COA system, product-specific laboratory records, public pricing, detailed testing claims, and extensive customer-facing policies. Researchers can search the lab-testing database by lot number or product name, and Healius states that matching COA PDFs are available for immediate download.
The supplier publicly states that each batch receives internal HPLC and mass-spectrometry testing followed by independent external verification, and current product pages display specific testing categories such as purity, weight, sterility, endotoxins, and heavy metals.
The strongest transparency signals are the searchable lot architecture, detailed public testing documentation, lot-specific COA access, visible pricing, and substantial contact and policy information. Areas requiring further review include reconciliation of differing descriptions of the standard third-party testing panel, direct PSR review of a representative sample of current laboratory reports, and clarification of fulfillment-location information across supplier pages.
PSR’s assessment reflects documentation transparency and evidence availability. It is not a certification or determination of product safety, efficacy, regulatory status, or suitability for human use.
01 / DOCUMENTATION REVIEW
Documentation Quality
POSITIVE EVIDENCE
• Public lot-number COA search
• Product-name COA search
• Downloadable matching certificates stated available
• HPLC chromatograms stated included
• Mass-spectrometry traces stated included
• Third-party verification certificate stated included
• Batch/manufacturing dates stated included
• Release analyst signature stated included
• Public product pricing and stock status
• Public shipping, refund, FAQ, and compliance information
• Public London office address
• Regional support phone numbers
OPEN QUESTIONS
• Whether every active lot currently has a downloadable public COA
• Whether every product receives the same external testing panel
• Whether endotoxin, heavy-metal, sterility, residual-solvent, and water-content testing are standard or selected-lot additions
• Which independent laboratories are used for specific batches
• Whether all third-party lab reports can be externally verified by report ID
• How current UK and U.S. fulfillment references relate to actual shipping operations
• Whether historical COAs remain permanently accessible
PSR OBSERVATION
Healius Peptides provides a strong documentation framework, especially around lot-level COA lookup and detailed public testing descriptions. However, PSR identified differing descriptions of the standard third-party panel across current supplier pages. PSR therefore treats the documentation system as strong while reserving a higher testing score until those testing-scope differences are clarified and a broader sample of current laboratory reports is directly reviewed.
02 / TESTING EVIDENCE
Healius Peptides maintains a public lot-level testing database and states that every batch undergoes internal HPLC purity testing and mass-spectrometry identity testing followed by independent third-party verification. Current product pages publish batch-specific purity, measured mass, TFA, endotoxin, sterility, test-date, and lot-number information.
Public COA Search — Present · Lot Search — Present · HPLC Purity — Published · Mass / Content Data — Published · TFA Test — Published · Endotoxin Result — Published · Sterility Result — Published · Third-Party Verification — Supplier-Stated · External Laboratory Identity — Certificate-Level / Further PSR Review Needed
PSR NOTE
Healius Peptides provides unusually detailed lot-level testing information on its public product pages. However, PSR identified differing descriptions of the testing panel across current supplier pages and has not yet independently reviewed enough underlying third-party certificates to confirm the scope of testing across the entire catalog.
SUPPLIER-STATED
Claims made by Healius Peptides about catalog-wide testing practices, laboratory use, testing scope, batch release procedures, and fulfillment operations that PSR has not independently substantiated across every product and lot.
DOCUMENT OBSERVED
Information directly displayed in Healius Peptides’ public COA search, product pages, testing pages, policies, contact pages, and other publicly accessible supplier documentation.
PSR CONCLUSION
Healius provides strong public lot-level documentation and detailed testing data, but PSR identified inconsistencies in how the supplier describes its standard third-party testing panel. The preliminary assessment therefore remains strong, but not elite, pending broader certificate verification and clarification of testing scope.
03 / SAMPLE COA OBSERVATIONS
CERTIFICATE 01 / DOCUMENT OBSERVED
PT-141 10 mg
Lot
HP3001777629-10
Date Tested
February 2, 2026
Supplier-Published HPLC Purity
99.88%
Measured Mass
12.5 mg
TFA Test
Not Detected
Endotoxins (LPS)
Pass
Sterility
Pass
Direct PSR Third-Party Certificate Review
Pending
CERTIFICATE 02 / DOCUMENT OBSERVED
DSIP 15 mg
Lot
HP4519174383-15
Date Tested
February 2, 2026
Supplier-Published HPLC Purity
99.71%
Measured Mass
15.8 mg
TFA Test
Not Detected
Endotoxins (LPS)
Pass
Sterility
Pass
Direct PSR Third-Party Certificate Review
Pending
The lot numbers and analytical results above were directly observed on current Healius Peptides product pages. PSR has not yet independently validated the underlying third-party laboratory certificates for these specific lots. Accordingly, these results are classified as supplier-published lot data rather than independently verified PSR laboratory findings.
04 / LOT TRACEABILITY
Lot Traceability
Healius Peptides provides strong public lot-level traceability through a searchable testing database, lot identifiers on product pages, and batch-specific analytical results. Researchers can search by lot number or product name, and current product pages display specific lot codes tied to testing dates and analytical data.
Positive Indicators
• Public lot-number search
• Public product-name search
• Specific lot codes shown on product pages
• Test dates tied to lot records
• Purity and measured-mass data tied to lot records
• Endotoxin and sterility results shown on some current lot pages
• Matching COA retrieval stated available
• Batch-specific documentation architecture
Limitation
PSR has not independently verified the complete chain of custody from manufacturing through laboratory submission, warehousing, and final fulfillment. Healius’ lot-search system and batch-level data provide strong documentation traceability, but they do not by themselves establish an independently observed end-to-end chain of custody.
05 / PRICING VISIBILITY
Pricing Visibility
Healius Peptides provides strong public pricing visibility. Product pages display listed prices, sale prices, available strengths, stock status, and quantity-based discounts without requiring an account, making direct supplier comparison relatively straightforward.
PSR Observation — Healius Peptides provides excellent pricing transparency. Researchers can review current list prices, sale prices, product strengths, stock status, and quantity-discount information before checkout without creating an account. This supports a high Pricing Transparency score.
06 / COMPANY & SUPPLIER TRANSPARENCY
Supplier Name — Healius Peptides · Public Company Name — Healius Peptides Ltd. · Office Address Listed — London, United Kingdom · Public Support Email — Available · Regional Support Phone Numbers — Available · Shipping Policy — Available · Refund Policy — Available · FAQ / Compliance Information — Available · Research-Use Disclaimer — Available
PSR Observation — Healius Peptides provides substantial public-facing company and support information, including a London office address, multiple regional support numbers, detailed FAQ and policy pages, and research-use disclosures. However, current supplier materials also reference different fulfillment locations and testing descriptions, so PSR treats operational-location and testing-scope consistency as areas requiring additional context rather than as evidence of misconduct.
ITEMS REQUIRING CONTEXT
UK office vs. U.S./other fulfillment references · Clarification of exact legal/operating structure across regions · Consistency of third-party testing descriptions · Identification of specific external laboratories by batch
07 / EVIDENCE CLASSIFICATION
VERIFIED IN PUBLIC DOCUMENTATION — PSR directly observed Healius Peptides’ public lot-search system, product-name search, lot-specific testing data, supplier-published purity and measured-mass results, endotoxin and sterility fields on current product pages, public pricing, contact information, regional support numbers, policy pages, and research-use disclosures. SUPPLIER-STATED — Healius Peptides states that every batch receives internal HPLC and mass-spectrometry testing followed by independent third-party verification, and that broader testing may include endotoxins, heavy metals, bioburden, residual solvents, sterility, and water-content analysis. NOT DETERMINED — PSR has not yet independently verified a representative sample of underlying third-party laboratory certificates, confirmed that every active lot receives the same testing panel, established complete chain of custody, or fully reconciled differing descriptions of fulfillment locations and testing scope across current supplier pages.
08 / BALANCED ASSESSMENT
DOCUMENTATION STRENGTHS
Public lot-number COA search · Product-name search · Lot-specific testing data · Supplier-published purity and measured-mass results · Endotoxin and sterility fields on current product pages · Public pricing · Public stock status · Detailed FAQ and testing pages · Public contact information · Regional support numbers · Public research-use policies
AREAS FOR FURTHER REVIEW
Direct review of more underlying third-party laboratory certificates · Consistency of testing panels across all active lots · Clarification of standard vs. extended testing · Identification of external laboratories by batch · Complete chain-of-custody verification · Fulfillment-location consistency · Long-term historical COA accessibility
PSR ASSESSMENT
Preliminary PSR Transparency Score: 88 / 100 — Strong Transparency
Healius Peptides presents a strong public documentation framework, particularly through its lot-level search system, detailed batch information, public testing fields, pricing visibility, and extensive customer-facing policies. These features support a Strong preliminary PSR transparency rating.
The main limitation is not lack of information, but consistency across that information. PSR identified differing descriptions of the supplier’s standard third-party testing panel and has not yet independently reviewed enough underlying laboratory certificates to confirm the breadth of testing across the full catalog. PSR therefore gives Healius strong credit for documentation accessibility while reserving a higher score until testing scope and certificate evidence are more fully reconciled.
09 / SOURCES REVIEWED
Healius Peptides official website - Healius Peptides lab-testing / COA search pages - Healius Peptides product pages - Healius Peptides FAQ - Healius Peptides contact page - Healius Peptides shipping / refund / policy pages - Healius Peptides affiliate program page - Public supplier testing statements and lot-level product data
DISCLAIMER
PSR evaluates supplier transparency and publicly available documentation for informational and research purposes. A PSR score is not a certification, laboratory guarantee, medical recommendation, safety determination, regulatory approval, or guarantee of product identity, purity, efficacy, legality, or suitability for human or animal use. Supplier-published lot data and catalog-wide testing claims remain classified according to the evidence directly available to PSR at the time of review.